1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Clore, G.M.
Werner, M.H.
Huth, J.R.
Gronenborn, A.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C10 H14 N5 O6 P
331.222
y
2'-DEOXYADENOSINE-5'-MONOPHOSPHATE
DNA linking
C9 H14 N3 O7 P
307.197
y
2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE
DNA linking
C10 H14 N5 O7 P
347.221
y
2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE
DNA linking
C10 H15 N2 O8 P
322.208
y
THYMIDINE-5'-MONOPHOSPHATE
DNA linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
81
704
705
10.1016/0092-8674(95)90532-4
7774012
Molecular basis of human 46X,Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex.
1995
10.2210/pdb1hry/pdb
pdb_00001hry
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2404.621
DNA (5'-D(*GP*CP*AP*CP*AP*AP*AP*C)-3')
1
syn
polymer
2448.613
DNA (5'-D(*GP*TP*TP*TP*GP*TP*GP*C)-3')
1
syn
polymer
9508.031
HUMAN SRY
1
nat
polymer
DEOXYRIBONUCLEIC ACID
DEOXYRIBONUCLEIC ACID
POLYPEPTIDE
no
no
(DG)(DC)(DA)(DC)(DA)(DA)(DA)(DC)
GCACAAAC
B
polydeoxyribonucleotide
no
no
(DG)(DT)(DT)(DT)(DG)(DT)(DG)(DC)
GTTTGTGC
C
polydeoxyribonucleotide
no
no
VQDRVKRPMNAFIVWSRDQRRKMALENPRMRNSEISKQLGYQWKMLTEAEKWPFFQEAQKLQAMHREKYPNYKYRP
VQDRVKRPMNAFIVWSRDQRRKMALENPRMRNSEISKQLGYQWKMLTEAEKWPFFQEAQKLQAMHREKYPNYKYRP
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
-1.530
1
19
B
1
C
8
-0.357
B_DG1:DC8_C
1
0.324
0.540
-0.091
0.214
7.429
1
19
B
2
C
7
0.190
B_DC2:DG7_C
2
-3.014
-0.616
-0.672
0.149
3.416
1
20
B
3
C
6
-0.546
B_DA3:DT6_C
3
-5.665
-0.071
-0.498
0.149
2.123
1
19
B
4
C
5
1.097
B_DC4:DG5_C
4
3.059
-0.135
-0.069
0.273
-4.188
1
20
B
5
C
4
0.542
B_DA5:DT4_C
5
-5.319
0.273
-0.471
0.246
7.944
1
20
B
6
C
3
-11.638
B_DA6:DT3_C
6
-0.737
0.133
-0.462
0.153
10.482
1
20
B
7
C
2
-16.683
B_DA7:DT2_C
7
11.179
0.244
-0.313
0.198
15.610
1
19
B
8
C
1
1.231
B_DC8:DG1_C
8
-2.466
-0.672
-0.570
0.201
2.519
29.336
B
B
1
2
42.200
C
C
8
7
3.286
19.530
0.264
0.066
BB_DG1DC2:DG7DC8_CC
1
3.479
-7.518
21.721
-4.193
0.249
2.830
46.777
B
B
2
3
46.843
C
C
7
6
3.735
33.660
-0.340
0.219
BB_DC2DA3:DT6DG7_CC
2
-1.261
1.755
32.940
-3.097
0.302
3.403
29.246
B
B
3
4
22.832
C
C
6
5
3.779
11.202
-0.113
-0.192
BB_DA3DC4:DG5DT6_CC
3
-4.306
8.777
26.719
-3.173
-0.850
4.288
34.703
B
B
4
5
18.995
C
C
5
4
4.340
11.123
0.179
0.539
BB_DC4DA5:DT4DG5_CC
4
3.406
-5.817
32.752
-1.414
0.409
3.332
30.340
B
B
5
6
41.320
C
C
4
3
3.918
19.898
-1.246
0.561
BB_DA5DA6:DT3DT4_CC
5
0.460
-0.955
23.016
-4.013
2.498
4.071
25.487
B
B
6
7
1.642
C
C
3
2
4.107
0.723
0.128
-0.010
BB_DA6DA7:DT2DT3_CC
6
-2.631
5.976
25.342
-0.281
-1.234
3.264
22.553
B
B
7
8
25.484
C
C
2
1
3.880
9.649
0.214
-0.559
BB_DA7DC8:DG1DT2_CC
7
-1.059
2.796
20.382
-5.488
-0.994
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1995-09-15
1
1
2008-03-03
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
ENSEMBLE OF 35 STRUCTURES
Y
BNL
1995-05-09
REL
REL
chemically synthesized
sample
chemically synthesized
sample
72
1805
444
107
221
386
40
72
271
71
10
THE 3D STRUCTURE OF THE HUMAN SRY-DNA COMPLEX SOLVED BY MULTI-DIMENSIONAL HETERONUCLEAR-EDITED AND -FILTERED NMR IS BASED ON 1805 EXPERIMENTAL RESTRAINTS: (A) INTRA-PROTEIN: 290 SEQUENTIAL (|I-J|=1), 221 MEDIUM RANGE (1 < |I-J| >=5) AND 107 LONG RANGE (|I-J| >5) INTERRESIDUES. 238 INTRARESIDUE APPROXIMATE INTERPROTON DISTANCE RESTRAINTS; 70 DISTANCE RESTRAINTS FOR 35 HYDROGEN BONDS; 153 TORSION ANGLE (71 PHI, 10 PSI, 56 CHI1 AND 16 CHI2) RESTRAINTS; 56 THREE-BOND HN-HA COUPLING CONSTANT RESTRAINTS; 145 (73 CALPHA AND 72 CBETA) 13C SHIFT RESTRAINTS. (B) INTRA-DNA: 206 INTRARESIDUE, 96 SEQUENTIAL INTRASTRAND, 36 INTERSTRAND INTERPROTON DISTANCE RESTRAINTS; 40 H-BOND RESTRAINTS; 72 TORSION ANGLE RESTRAINTS (FOR ALPHA, BETA, GAMMA, EPSILON AND ZETA BACKBONE TORSION ANGLES. (C) INTERMOLECULAR: 75 INTERPROTON DISTANCE RESTRAINTS
1
NUMBER OF ATOMS USED IN REFINEMENT.
NUMBER OF PROTEIN ATOMS 644
NUMBER OF NUCLEIC ACID ATOMS 322
NUMBER OF HETEROGEN ATOMS 0
NUMBER OF SOLVENT ATOMS 0
THE STRUCTURES WERE CALCULATED USING THE SIMULATED
ANNEALING PROTOCOL OF NILGES ET AL. (1988) FEBS LETT. 229,
129 - 136 USING THE PROGRAM X-PLOR 3.1 (BRUNGER) MODIFIED
TO INCORPORATE COUPLING CONSTANT (GARRETT ET AL. (1984) J.
MAGN. RESON. SERIES B 104, 99 - 103) AND CARBON CHEMICAL
SHIFT RESTRAINTS (KUSZEWSKI ET AL. (1995) MAGN. RESON.
SERIES B 106, 92 - 96).
THE 3D STRUCTURE OF THE HUMAN SRY-DNA COMPLEX SOLVED BY
MULTI-DIMENSIONAL HETERONUCLEAR-EDITED AND -FILTERED NMR
IS BASED ON 1805 EXPERIMENTAL RESTRAINTS:
(A) INTRA-PROTEIN:
290 SEQUENTIAL (|I-J|=1),
221 MEDIUM RANGE (1 < |I-J| >=5) AND
107 LONG RANGE (|I-J| >5) INTERRESIDUES.
238 INTRARESIDUE APPROXIMATE INTERPROTON DISTANCE
RESTRAINTS;
70 DISTANCE RESTRAINTS FOR 35 HYDROGEN BONDS;
153 TORSION ANGLE (71 PHI, 10 PSI, 56 CHI1 AND 16 CHI2)
RESTRAINTS;
56 THREE-BOND HN-HA COUPLING CONSTANT RESTRAINTS;
145 (73 CALPHA AND 72 CBETA) 13C SHIFT RESTRAINTS.
(B) INTRA-DNA:
206 INTRARESIDUE,
96 SEQUENTIAL INTRASTRAND,
36 INTERSTRAND INTERPROTON DISTANCE RESTRAINTS;
40 H-BOND RESTRAINTS;
72 TORSION ANGLE RESTRAINTS (FOR ALPHA, BETA, GAMMA,
EPSILON AND ZETA BACKBONE TORSION ANGLES.
(C) INTERMOLECULAR:
75 INTERPROTON DISTANCE RESTRAINTS
THE STRUCTURE IN THIS ENTRY IS THE RESTRAINED REGULARIZED
MEAN STRUCTURE. THE LAST COLUMN REPRESENTS THE RMS OF THE
35 INDIVIDUAL SIMULATED ANNEALING STRUCTURES ABOUT THE MEAN
COORDINATE POSITIONS. THE 35 INDIVIDUAL STRUCTURES CAN BE
FOUND IN PDB ENTRY 1HRZ. THE LAST COLUMN IN THE INDIVIDUAL
SA STRUCTURES HAS NO MEANING.
simulated annealing
BRUNGER
refinement
X-PLOR
G
1
n
1
DG
1
B
C
2
n
2
DC
2
B
A
3
n
3
DA
3
B
C
4
n
4
DC
4
B
A
5
n
5
DA
5
B
A
6
n
6
DA
6
B
A
7
n
7
DA
7
B
C
8
n
8
DC
8
B
G
1
n
1
DG
1
C
T
2
n
2
DT
2
C
T
3
n
3
DT
3
C
T
4
n
4
DT
4
C
G
5
n
5
DG
5
C
T
6
n
6
DT
6
C
G
7
n
7
DG
7
C
C
8
n
8
DC
8
C
n
1
1
A
n
2
2
A
ASP
3
n
3
ASP
3
A
ARG
4
n
4
ARG
4
A
VAL
5
n
5
VAL
5
A
LYS
6
n
6
LYS
6
A
ARG
7
n
7
ARG
7
A
PRO
8
n
8
PRO
8
A
MET
9
n
9
MET
9
A
ASN
10
n
10
ASN
10
A
ALA
11
n
11
ALA
11
A
PHE
12
n
12
PHE
12
A
ILE
13
n
13
ILE
13
A
VAL
14
n
14
VAL
14
A
TRP
15
n
15
TRP
15
A
SER
16
n
16
SER
16
A
ARG
17
n
17
ARG
17
A
ASP
18
n
18
ASP
18
A
GLN
19
n
19
GLN
19
A
ARG
20
n
20
ARG
20
A
ARG
21
n
21
ARG
21
A
LYS
22
n
22
LYS
22
A
MET
23
n
23
MET
23
A
ALA
24
n
24
ALA
24
A
LEU
25
n
25
LEU
25
A
GLU
26
n
26
GLU
26
A
ASN
27
n
27
ASN
27
A
PRO
28
n
28
PRO
28
A
ARG
29
n
29
ARG
29
A
MET
30
n
30
MET
30
A
ARG
31
n
31
ARG
31
A
ASN
32
n
32
ASN
32
A
SER
33
n
33
SER
33
A
GLU
34
n
34
GLU
34
A
ILE
35
n
35
ILE
35
A
SER
36
n
36
SER
36
A
LYS
37
n
37
LYS
37
A
GLN
38
n
38
GLN
38
A
LEU
39
n
39
LEU
39
A
GLY
40
n
40
GLY
40
A
TYR
41
n
41
TYR
41
A
GLN
42
n
42
GLN
42
A
TRP
43
n
43
TRP
43
A
LYS
44
n
44
LYS
44
A
MET
45
n
45
MET
45
A
LEU
46
n
46
LEU
46
A
THR
47
n
47
THR
47
A
GLU
48
n
48
GLU
48
A
ALA
49
n
49
ALA
49
A
GLU
50
n
50
GLU
50
A
LYS
51
n
51
LYS
51
A
TRP
52
n
52
TRP
52
A
PRO
53
n
53
PRO
53
A
PHE
54
n
54
PHE
54
A
PHE
55
n
55
PHE
55
A
GLN
56
n
56
GLN
56
A
GLU
57
n
57
GLU
57
A
ALA
58
n
58
ALA
58
A
GLN
59
n
59
GLN
59
A
LYS
60
n
60
LYS
60
A
LEU
61
n
61
LEU
61
A
GLN
62
n
62
GLN
62
A
ALA
63
n
63
ALA
63
A
MET
64
n
64
MET
64
A
HIS
65
n
65
HIS
65
A
ARG
66
n
66
ARG
66
A
GLU
67
n
67
GLU
67
A
LYS
68
n
68
LYS
68
A
TYR
69
n
69
TYR
69
A
PRO
70
n
70
PRO
70
A
ASN
71
n
71
ASN
71
A
TYR
72
n
72
TYR
72
A
LYS
73
n
73
LYS
73
A
TYR
74
n
74
TYR
74
A
ARG
75
n
75
ARG
75
A
n
76
76
A
author_defined_assembly
3
trimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
VAL
1
C
VAL
1
1
Y
1
A
GLN
2
C
GLN
2
1
Y
1
A
PRO
76
C
PRO
76
1
Y
1
B
C3'
DA
5
WRONG HAND
1
C
C3'
DG
1
WRONG HAND
1
A
ARG
31
0.096
SIDE CHAIN
1
2.70
0.30
108.30
111.00
B
B
B
O4'
C1'
N9
DG
DG
DG
1
1
1
N
1
-4.14
0.50
104.30
100.16
B
B
B
C5
N7
C8
DG
DG
DG
1
1
1
N
1
7.15
0.50
113.10
120.25
B
B
B
N7
C8
N9
DG
DG
DG
1
1
1
N
1
-3.63
0.40
106.40
102.77
B
B
B
C8
N9
C4
DG
DG
DG
1
1
1
N
1
2.76
0.30
108.30
111.06
B
B
B
O4'
C1'
N1
DC
DC
DC
2
2
2
N
1
2.63
0.30
108.30
110.93
B
B
B
O4'
C1'
N9
DA
DA
DA
3
3
3
N
1
-3.84
0.50
103.90
100.06
B
B
B
C5
N7
C8
DA
DA
DA
3
3
3
N
1
6.25
0.50
113.80
120.05
B
B
B
N7
C8
N9
DA
DA
DA
3
3
3
N
1
-3.13
0.40
105.80
102.67
B
B
B
C8
N9
C4
DA
DA
DA
3
3
3
N
1
2.31
0.30
108.30
110.61
B
B
B
O4'
C1'
N1
DC
DC
DC
4
4
4
N
1
3.67
0.30
108.30
111.97
B
B
B
O4'
C1'
N9
DA
DA
DA
5
5
5
N
1
-3.01
0.50
129.30
126.29
B
B
B
N1
C2
N3
DA
DA
DA
5
5
5
N
1
-3.83
0.50
103.90
100.07
B
B
B
C5
N7
C8
DA
DA
DA
5
5
5
N
1
6.20
0.50
113.80
120.00
B
B
B
N7
C8
N9
DA
DA
DA
5
5
5
N
1
-3.17
0.40
105.80
102.63
B
B
B
C8
N9
C4
DA
DA
DA
5
5
5
N
1
2.07
0.30
108.30
110.37
B
B
B
O4'
C1'
N9
DA
DA
DA
6
6
6
N
1
-3.81
0.50
103.90
100.09
B
B
B
C5
N7
C8
DA
DA
DA
6
6
6
N
1
6.43
0.50
113.80
120.23
B
B
B
N7
C8
N9
DA
DA
DA
6
6
6
N
1
-3.33
0.40
105.80
102.47
B
B
B
C8
N9
C4
DA
DA
DA
6
6
6
N
1
3.75
0.30
108.30
112.05
B
B
B
O4'
C1'
N9
DA
DA
DA
7
7
7
N
1
-3.86
0.50
103.90
100.04
B
B
B
C5
N7
C8
DA
DA
DA
7
7
7
N
1
6.37
0.50
113.80
120.17
B
B
B
N7
C8
N9
DA
DA
DA
7
7
7
N
1
-3.08
0.40
105.80
102.72
B
B
B
C8
N9
C4
DA
DA
DA
7
7
7
N
1
2.19
0.30
108.30
110.49
B
B
B
O4'
C1'
N1
DC
DC
DC
8
8
8
N
1
2.98
0.30
108.30
111.28
C
C
C
O4'
C1'
N9
DG
DG
DG
1
1
1
N
1
-4.02
0.50
104.30
100.28
C
C
C
C5
N7
C8
DG
DG
DG
1
1
1
N
1
7.03
0.50
113.10
120.13
C
C
C
N7
C8
N9
DG
DG
DG
1
1
1
N
1
-3.70
0.40
106.40
102.70
C
C
C
C8
N9
C4
DG
DG
DG
1
1
1
N
1
2.60
0.30
108.30
110.90
C
C
C
O4'
C1'
N1
DT
DT
DT
2
2
2
N
1
1.83
0.30
108.30
110.13
C
C
C
O4'
C1'
N1
DT
DT
DT
3
3
3
N
1
2.75
0.30
108.30
111.05
C
C
C
O4'
C1'
N1
DT
DT
DT
4
4
4
N
1
3.11
0.30
108.30
111.41
C
C
C
O4'
C1'
N9
DG
DG
DG
5
5
5
N
1
-4.11
0.50
104.30
100.19
C
C
C
C5
N7
C8
DG
DG
DG
5
5
5
N
1
7.14
0.50
113.10
120.24
C
C
C
N7
C8
N9
DG
DG
DG
5
5
5
N
1
-3.71
0.40
106.40
102.69
C
C
C
C8
N9
C4
DG
DG
DG
5
5
5
N
1
3.77
0.30
108.30
112.07
C
C
C
O4'
C1'
N1
DT
DT
DT
6
6
6
N
1
2.21
0.30
108.30
110.51
C
C
C
O4'
C1'
N9
DG
DG
DG
7
7
7
N
1
-4.09
0.50
104.30
100.21
C
C
C
C5
N7
C8
DG
DG
DG
7
7
7
N
1
7.16
0.50
113.10
120.26
C
C
C
N7
C8
N9
DG
DG
DG
7
7
7
N
1
-3.68
0.40
106.40
102.72
C
C
C
C8
N9
C4
DG
DG
DG
7
7
7
N
1
2.32
0.30
108.30
110.62
C
C
C
O4'
C1'
N1
DC
DC
DC
8
8
8
N
1
C
C
C5
C7
DT
DT
2
2
0.037
0.006
1.496
1.533
N
1
A
PRO
8
-66.76
-173.11
1
A
ARG
17
-41.07
-77.01
1
A
ARG
31
-64.61
-74.71
1
A
ILE
35
-48.78
-15.60
1
A
LYS
51
-69.30
-78.70
1
A
PRO
53
-42.15
-76.64
1
A
PRO
70
-50.34
-70.10
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
THE 3D STRUCTURE OF THE HUMAN SRY-DNA COMPLEX SOLVED BY MULTID-DIMENSIONAL HETERONUCLEAR-EDITED AND-FILTERED NMR
1
N
N
2
N
N
3
N
N
A
ALA
11
C
ALA
11
HELX_P
A
GLU
26
C
GLU
26
1
1
16
A
GLU
34
C
GLU
34
HELX_P
A
MET
45
C
MET
45
1
2
12
A
GLU
48
C
GLU
48
HELX_P
A
LYS
68
C
LYS
68
1
3
21
hydrog
WATSON-CRICK
B
DG
1
A
N1
DG
1
1_555
C
DC
8
B
N3
DC
8
1_555
hydrog
WATSON-CRICK
B
DG
1
A
N2
DG
1
1_555
C
DC
8
B
O2
DC
8
1_555
hydrog
WATSON-CRICK
B
DG
1
A
O6
DG
1
1_555
C
DC
8
B
N4
DC
8
1_555
hydrog
WATSON-CRICK
B
DC
2
A
N3
DC
2
1_555
C
DG
7
B
N1
DG
7
1_555
hydrog
WATSON-CRICK
B
DC
2
A
N4
DC
2
1_555
C
DG
7
B
O6
DG
7
1_555
hydrog
WATSON-CRICK
B
DC
2
A
O2
DC
2
1_555
C
DG
7
B
N2
DG
7
1_555
hydrog
WATSON-CRICK
B
DA
3
A
N1
DA
3
1_555
C
DT
6
B
N3
DT
6
1_555
hydrog
WATSON-CRICK
B
DA
3
A
N6
DA
3
1_555
C
DT
6
B
O4
DT
6
1_555
hydrog
WATSON-CRICK
B
DC
4
A
N3
DC
4
1_555
C
DG
5
B
N1
DG
5
1_555
hydrog
WATSON-CRICK
B
DC
4
A
N4
DC
4
1_555
C
DG
5
B
O6
DG
5
1_555
hydrog
WATSON-CRICK
B
DC
4
A
O2
DC
4
1_555
C
DG
5
B
N2
DG
5
1_555
hydrog
WATSON-CRICK
B
DA
5
A
N1
DA
5
1_555
C
DT
4
B
N3
DT
4
1_555
hydrog
WATSON-CRICK
B
DA
5
A
N6
DA
5
1_555
C
DT
4
B
O4
DT
4
1_555
hydrog
WATSON-CRICK
B
DA
6
A
N1
DA
6
1_555
C
DT
3
B
N3
DT
3
1_555
hydrog
WATSON-CRICK
B
DA
6
A
N6
DA
6
1_555
C
DT
3
B
O4
DT
3
1_555
hydrog
WATSON-CRICK
B
DA
7
A
N1
DA
7
1_555
C
DT
2
B
N3
DT
2
1_555
hydrog
WATSON-CRICK
B
DA
7
A
N6
DA
7
1_555
C
DT
2
B
O4
DT
2
1_555
hydrog
WATSON-CRICK
B
DC
8
A
N3
DC
8
1_555
C
DG
1
B
N1
DG
1
1_555
hydrog
WATSON-CRICK
B
DC
8
A
N4
DC
8
1_555
C
DG
1
B
O6
DG
1
1_555
hydrog
WATSON-CRICK
B
DC
8
A
O2
DC
8
1_555
C
DG
1
B
N2
DG
1
1_555
DNA BINDING PROTEIN/DNA
DNA, SRY, DNA-BINDING PROTEIN, DNA BINDING PROTEIN-DNA COMPLEX
SRY_HUMAN
UNP
3
56
Q05066
1HRY
PDB
1
1HRY
1HRY
PDB
2
1HRY
56
131
1HRY
1
76
Q05066
A
1
1
76
1
8
1HRY
1
8
1HRY
B
2
1
8
1
8
1HRY
1
8
1HRY
C
3
1
8
1
P 1